These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. FDA could OK costly blood standards. An expert says that like chicken soup, removal of white cells from blood supply can't hurt. Hensley S Mod Healthc; 1999 Nov; 29(48):8. PubMed ID: 10662211 [No Abstract] [Full Text] [Related]
4. Photochemotherapy in systemic sclerosis. The stage is set. Trentham DE Arch Dermatol; 1992 Mar; 128(3):389-90. PubMed ID: 1550373 [No Abstract] [Full Text] [Related]
5. A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis. Knobler RM; French LE; Kim Y; Bisaccia E; Graninger W; Nahavandi H; Strobl FJ; Keystone E; Mehlmauer M; Rook AH; Braverman I; J Am Acad Dermatol; 2006 May; 54(5):793-9. PubMed ID: 16635659 [TBL] [Abstract][Full Text] [Related]
6. [Experience using d-penicillamine in systemic scleroderma]. Nemchinov EN; Krel' AA; Shekhter AB; Rashchupkina ZP Klin Med (Mosk); 1982 Jan; 60(1):77-82. PubMed ID: 7078046 [No Abstract] [Full Text] [Related]
7. [Penicillamine in the treatment of scleroderma]. Kobíková M; Stáva Z Cesk Dermatol; 1973 Dec; 48(6):408-10. PubMed ID: 4771784 [No Abstract] [Full Text] [Related]
8. Immunological alterations during photopheresis and D-penicillamine treatment of systemic sclerosis. Rietschel RL; Cooper ES Ann N Y Acad Sci; 1991 Dec; 636():400-2. PubMed ID: 1793227 [No Abstract] [Full Text] [Related]
9. Extracorporeal photochemotherapy in nodular scleroderma. Wollina U; Looks A; Lange D Br J Dermatol; 1998 Sep; 139(3):559-60. PubMed ID: 9767323 [No Abstract] [Full Text] [Related]
10. Extracorporeal photopheresis in systemic sclerosis: effects on organ involvement? Reich S; Gambichler T; Altmeyer P; Kreuter A J Am Acad Dermatol; 2007 Feb; 56(2):348-9. PubMed ID: 17224379 [No Abstract] [Full Text] [Related]